ReaScan CXCL13

ReaScan CXCL13 is an immunochromatographic rapid test for semiquantitative determination of chemokine CXCL13 in human cerebrospinal fluid (CSF). The test result is read from the test cassette with the ReaScan+ reader (REF 105100, Oy Reagena Ltd, Finland). The test is intended for in vitro diagnostic laboratory use by healthcare professionals.

Test performance:
Specificity 96 % (CSF) Sensitivity 100 % (CSF) with cut-off 250 pg/mL

Product Code:
ReaScan+ reader is sold separately (105100)

Package Size:
10 tests

Haglund S et al. 2022. CXCL13 in laboratory diagnosis of Lyme neuroborreliosis-the performance of the recomBead and ReaScan CXCL13 assays in human cerebrospinal fluid samples. Eur J Clin Microbiol Infect Dis. Jan;41(1):175-179.

Ziegler et al. 2020. Comparative Analysis of the Euroimmun CXCL13 Enzyme-Linked Immunosorbent Assay and the ReaScan Lateral Flow Immunoassay for Diagnosis of Lyme Neuroborreliosis. J Clin Microbiol. Aug 24;58(9):e00207-20.

Pietikäinen A et al. 2018. Point-of-care testing for CXCL13 in Lyme neuroborreliosis. Diagn Microbiol Infect Dis. Jul;91(3):226–228.